The frequency of BRAF alterations in this group is lower when compared to other malignancies, including CRC (10%)3,4 and melanoma (50%).27 To our knowledge, this is one of few studies reporting prognostic implications of BRAF mutations in non-CRC GI malignancies. Here, BRAF is linked to melanoma.